In vivo properties of oncostatin M.

Annals of the New York Academy of SciencesVolume 762, Issue 1 p. 42-54 In Vivo Properties of Oncostatin M PHILIP M. WALLACE, Corresponding Author PHILIP M. WALLACE Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Author to whom correspondence should be addressed: Tel: (206) 727-3735; Fax: (206) 727-3603.Search for more papers by this authorJOHN F. MACMASTER, JOHN F. MACMASTER Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Search for more papers by this authorJILL R. RILLEMA, JILL R. RILLEMA Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Search for more papers by this authorKATHERINE A. ROULEAU, KATHERINE A. ROULEAU Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Search for more papers by this authorMARCIA B. HANSON, MARCIA B. HANSON Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Search for more papers by this authorSAMUEL A. BURSTEIN, SAMUEL A. BURSTEIN W. k. Warren Medical Research Institute Department of Medicine University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma 73190Search for more papers by this authorMOHAMMED SHOYAB, MOHAMMED SHOYAB Department of Pathobiology, F-167 Health Science Building, SC-38, University of Washington, Seattle, WA 98195.Search for more papers by this author PHILIP M. WALLACE, Corresponding Author PHILIP M. WALLACE Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Author to whom correspondence should be addressed: Tel: (206) 727-3735; Fax: (206) 727-3603.Search for more papers by this authorJOHN F. MACMASTER, JOHN F. MACMASTER Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Search for more papers by this authorJILL R. RILLEMA, JILL R. RILLEMA Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Search for more papers by this authorKATHERINE A. ROULEAU, KATHERINE A. ROULEAU Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Search for more papers by this authorMARCIA B. HANSON, MARCIA B. HANSON Bristol-Myers SquibbPharmaceutical Research Institute 3005 First Avenue Seattle, Washington 98121Search for more papers by this authorSAMUEL A. BURSTEIN, SAMUEL A. BURSTEIN W. k. Warren Medical Research Institute Department of Medicine University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma 73190Search for more papers by this authorMOHAMMED SHOYAB, MOHAMMED SHOYAB Department of Pathobiology, F-167 Health Science Building, SC-38, University of Washington, Seattle, WA 98195.Search for more papers by this author First published: July 1995 https://doi.org/10.1111/j.1749-6632.1995.tb32313.xCitations: 16 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume762, Issue1Interleukin‐6‐Type CytokinesJuly 1995Pages 42-54 RelatedInformation